10. Drug allergy.

Adverse drug reactions are common, but only 6% to 10% are immunologically mediated. Unlike most adverse drug reactions, allergic drug reactions are unpredictable. Whereas some drug-induced allergic reactions may be easily classified into one of the four Gell and Coombs hypersensitivity categories, many others that appear to have an immunologic component cannot be classified because of our lack of mechanistic information. Theoretically, any drug can induce an immune response. However, some drugs are more likely to elicit clinically relevant immune responses than are others. Drugs in this category include antimicrobial drugs, anticonvulsants, chemotherapeutic agents, heparin, insulin, protamine, and biologic response modifiers. After a drug-disease connection is established, it must be determined whether the reaction was immunologically mediated. Subsequently, confirmatory tests, if available, should be used to determine the allergic status of the patient. If these tests are not available, a graded challenge or desensitization may be considered, depending on the type of clinical reaction previously demonstrated and the need for drug readministration. Education of the patient and primary care physician is an important component of patient management.

[1]  S. Spielberg,et al.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. , 1988, The Journal of clinical investigation.

[2]  G. Beall,et al.  Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients. , 1994, The Journal of allergy and clinical immunology.

[3]  J. Nelson,et al.  Management of heparin allergy in pregnancy , 2001, American journal of hematology.

[4]  I. Moll,et al.  Management of insulin allergy , 2001, Allergy. European Journal of Allergy and Clinical Immunology.

[5]  H. S. Earl,et al.  Studies of human IgE to a sulfonamide determinant. , 1987, The Journal of allergy and clinical immunology.

[6]  R. Lawrence,et al.  Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children. , 1996, The Pediatric infectious disease journal.

[7]  R. Moscicki,et al.  Adverse reactions to heparin. , 1990, Annals of allergy.

[8]  R. Simon,et al.  Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. , 2001, The Journal of allergy and clinical immunology.

[9]  P. Gell,et al.  Clinical aspects of immunology , 1968 .

[10]  H. Wedner,et al.  Skin testing to detect penicillin allergy. , 1981, The Journal of allergy and clinical immunology.

[11]  B. Baldo,et al.  Penicillins and cephalosporins as allergens — structural aspects of recognition and cross‐reactions , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  C. Katlama,et al.  Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus. , 1997, Archives of dermatology.

[13]  O. Idsøe,et al.  Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. , 1968, Bulletin of the World Health Organization.

[14]  L. Rybicki,et al.  Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Relling,et al.  Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia , 1998, Leukemia.

[16]  M. Fischl,et al.  Rapid oral desensitization for sulfonamides in patients with the acquired immunodeficiency syndrome. , 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[17]  K. Arndt,et al.  Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. , 1986, JAMA.

[18]  M. Markman,et al.  Prevention and Management of Antineoplastic-Induced Hypersensitivity Reactions , 2001, Drug safety.

[19]  H. Hori,et al.  Rapid desensitization for L-asparaginase hypersensitivity. , 1998, The Journal of allergy and clinical immunology.

[20]  B. Levine,et al.  Minor haptenic determinant-specific reagins of penicillin hypersensitivity in man. , 1969, International archives of allergy and applied immunology.

[21]  C. Ritchlin,et al.  Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein. , 2001, Archives of dermatology.

[22]  P. Woster,et al.  A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. , 2000, The Journal of investigative dermatology.

[23]  S. Knowles,et al.  Anticonvulsant Hypersensitivity Syndrome , 1999, Drug safety.

[24]  H. Jick,et al.  Assessment of adverse reactions within a drug surveillance program. , 1968, JAMA.

[25]  W. Lorenz,et al.  Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent , 1977, Agents and Actions.

[26]  L. C. Sweet,et al.  Evaluation of penicillin hypersensitivity: value of clinical history and skin testing with penicilloyl-polylysine and penicillin G. A cooperative prospective study of the penicillin study group of the American Academy of Allergy. , 1977, The Journal of allergy and clinical immunology.

[27]  J. Sastre,et al.  Lack of allergic cross‐reactivity to cephalosporins among patients allergic to penicillins , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[28]  A. Neugut,et al.  Anaphylaxis in the United States: an investigation into its epidemiology. , 2001, Archives of internal medicine.

[29]  N. Adkinson,et al.  Immediate hypersensitivity reactions to penicillin and related antibiotics , 1988, Clinical allergy.

[30]  W. Pichler,et al.  Role of T cells in drug allergies , 1998, Allergy.

[31]  J. Roujeau,et al.  Physiopathology and treatment of severe drug eruptions , 2001, Current opinion in allergy and clinical immunology.

[32]  R. Gruchalla Acute drug desensitization. , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[33]  L. Lichtenstein,et al.  Routine use of penicillin skin testing on an inpatient service. , 1971, The New England journal of medicine.

[34]  P. Fritsch,et al.  Delayed‐Type Hypersensitivity and Cross‐Reactivity to Heparins and Danaparoid: A Prospective Study , 2001, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[35]  B. Leyland-Jones,et al.  Hypersensitivity reactions to teniposide (VM-26): an analysis. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  I. Bernstein,et al.  Disease management of drug hypersensitivity: A practice parameter: Preface , 1999 .

[37]  S. Spielberg,et al.  Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine. , 1990, Drug metabolism and disposition: the biological fate of chemicals.

[38]  E. Pratt,et al.  Localized insulin allergy treated with continuous subcutaneous insulin , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[39]  Fusco,et al.  Carboplatin hypersensitivity reactions in patients with ovarian and peritoneal carcinoma , 1998 .

[40]  R. Reisman,et al.  Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. , 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[41]  H. Friedman,et al.  Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions. , 1996, Medical and pediatric oncology.

[42]  Wan Ariffin Bin Abdullah,et al.  Med Pediatr Oncol , 1999 .

[43]  R. Gelber,et al.  Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to escherichia coli asparaginase , 1992, Cancer.

[44]  D. Davies,et al.  Textbook of Adverse Drug Reactions , 1992, Annals of Internal Medicine.

[45]  P. Lieberman,et al.  Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin. , 1994, The Journal of allergy and clinical immunology.

[46]  R. Valenta,et al.  Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens. , 2000, The Journal of allergy and clinical immunology.

[47]  S. Oka,et al.  A 5-day course of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type-1 infection who were previously intolerant to T/S. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[48]  M. Markman,et al.  Paclitaxel-associated hypersensitivity reactions: experience of the gynecologic oncology program of the Cleveland Clinic Cancer Center. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  W. Pichler,et al.  Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. , 2000, The Journal of allergy and clinical immunology.

[50]  C. Bayerl,et al.  Association of heparin‐induced skin lesions, intracutaneous tests, and heparin‐induced IgG , 1999, Allergy.

[51]  J. Bousquet,et al.  Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients. , 1998, The Journal of allergy and clinical immunology.

[52]  B. Levine Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man. , 1966, The New England journal of medicine.

[53]  M. Markowitz Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever , 1991 .

[54]  G. Kearns,et al.  Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility. , 1994, The Journal of pediatrics.

[55]  R. Lin A perspective on penicillin allergy. , 1992, Archives of internal medicine.

[56]  J B Vermorken,et al.  European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  R. Gruchalla,et al.  Detection of human IgE to sulfamethoxazole by skin testing with sulfamethoxazoyl-poly-L-tyrosine. , 1991, The Journal of allergy and clinical immunology.

[58]  E. Middleton,et al.  Allergy, principles and practice , 1978 .

[59]  R. Patterson,et al.  Drug allergy and protocols for management of drug allergies. , 1995, Allergy proceedings : the official journal of regional and state allergy societies.

[60]  M. Laxenaire Épidémiologie des réactions anaphylactoïdes peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996) , 1999 .

[61]  T. Casale,et al.  Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. , 1992, Archives of internal medicine.

[62]  P. Gorevic,et al.  Desensitization of anaphylactic hypersensitivity specific for the penicilloate minor determinant of penicillin and carbenicillin. , 1981, The Journal of allergy and clinical immunology.

[63]  D. Skiest,et al.  Sulfonamide-induced reactions in desensitized patients with AIDS--the role of covalent protein haptenation by sulfamethoxazole. , 1998, The Journal of allergy and clinical immunology.

[64]  N. Adkinson,et al.  DIAGNOSTIC TESTING FOR DRUG HYPERSENSITIVITY , 1998, Radiologic Clinics of North America.

[65]  Dominic P. Williams,et al.  Reactive metabolites and their role in drug reactions , 2001, Current opinion in allergy and clinical immunology.

[66]  M. Pirmohamed,et al.  Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism‐dependent haptenation and T‐cell proliferation in vivo , 2001, British journal of pharmacology.

[67]  J. Rich,et al.  Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons. , 1997, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[68]  M Pirmohamed,et al.  Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity , 1999, British journal of pharmacology.

[69]  Pumphrey Lessons for management of anaphylaxis from a study of fatal reactions , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[70]  C. W. Parker,et al.  Drug allergy (first of three parts). , 1975, The New England journal of medicine.

[71]  R. Nicklas The diagnosis and management of anaphylaxis , 2005 .

[72]  C. Pui,et al.  Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukemia , 1991, Cancer.